Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance

References

• Barton HA, Chiu WA, Setzer RW, Andersen ME, Bailer AJ, Bois FY, DeWoskin RS, Hays S, Johanson G, Jones N, Loizou G. 2007. Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation. Toxicol Sci. 99:395–402.
   PubMed Web of Science ®Google Scholar
• Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, Sachana M, Segner H, Van Der Burg B, Villeneuve DL, Watanabe H. 2015. Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence. Reg Toxicol Pharmacol. 72:514–537.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Zhang Q, Carmichael PL, Boekelheide K, Andersen ME. 2011. Toxicity testing in the 21 st century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways. PLoS One 6:e20887.
   PubMed Web of Science ®Google Scholar
• Codex Alimentarius Commission. 2013. Codex Alimentarius Commission Procedural Manual. Twenty-first edition. World Health Organization, Food and Agriculture Organization of the United Nations. Rome, 2013. Available from: http://www.fao.org/3/a-i3243e.pdf
   Google Scholar
• Clewell HJ, Gentry PR, Covington TR, Sarangapani R, Teeguarden JG. 2004. Evaluation of the potential impact of age- and gender specific pharmacokinetic differences on tissue dosimetry. Toxicol Sci. 79:381–393.
   PubMed Web of Science ®Google Scholar
• Dorne JL. 2007. Human variability in hepatic and renal elimination: implications for risk assessment. J Appl Toxicol. 27:411–420.
   PubMed Web of Science ®Google Scholar
• Dorne JL, Walton K, Renwick AG. 2005. Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. Food Chem. Toxicol. 43:203–216.
   PubMed Web of Science ®Google Scholar
• ECHA (European Chemical Agency). 2012. Guidance on information requirements and chemical safety assessment – Chapter R.8: Characterisation of dose [concentration]–response for human health. Version 2.1. Helisnki, Finland. [cited 2016 Jan 7]. Available from: https://echa.europa.eu/documents/10162/13632/information_requirements_r8_en.pdf
   Google Scholar
• Edwards SW, Tan YM, Villeneuve DL, Meek ME, McQueen CA. 2016. Adverse outcome pathways—organizing toxicological information to improve decision making. J Pharmacol Exper Ther. 356:170–181.
   PubMed Web of Science ®Google Scholar
• EFSA (European Food Safety Authority). 2006. Opinion of the scientific panel on plant protection products and their residues (PPR Panel) on a request from the Commission on the Safety of Aldicarb MRLs. EFSA J. 409:1–23.
   Google Scholar
• EFSA (European Food Safety Authority). 2008. Scientific Opinion on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. Panel on Contaminants in the Food Chain (CONTAM). Question Number: EFSA-Q-2004-163. [cited 2016 Jan 6]. Available from: http://www.efsa.europa.eu/en/efsajournal/pub/653
   Google Scholar
• EFSA (European Food Safety Authority). 2009. Scientific opinion. Cadmium in food. Panel on Contaminants in the Food Chain (CONTAM). Question No EFSA-Q-2007-138. EFSA J. 980:1–139. Available from: http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/contam_op_ej980_cadmium_en_rev.1%2C2.pdf
   Google Scholar
• EFSA (European Food Safety Authority). 2011. Scientific Report: Comparison of the Approaches Taken by EFSA and JECFA to Establish a HBGV for Cadmium. EFSA, Parma, Italy. Available from: http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/2006.pdf
   Google Scholar
• EFSA (European Food Safety Authority). 2012. Scientific Opinion on the risk for public health related to the presence of mercury and methylmercury in food. Panel on Contaminants in the Food Chain (CONTAM). Question Number: EFSA-Q-2011-00923. EFSA J. 10:2985.
   Google Scholar
• EFSA (European Food Safety Authority). 2015a. Guidance on Uncertainty in EFSA Scientific Assessment EFSA Scientific Committee (draft). [cited 2016 Jan 6]. Available from: http://www.efsa.europa.eu/sites/default/files/consultation/150618.pdf
   Google Scholar
• EFSA (European Food Safety Authority). 2015b. Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs: PART II – Toxicological assessment and risk characterisation. EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) European Food Safety Authority (EFSA), Parma, Italy. Available from: http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/3978part2.pdf
   Google Scholar
• Fujita T, Matsumoto Y, Ozaki M, Majima M, Kumagai Y, Ohtani Y. 2006. Comparison of maximum drug concentration and area under the time–concentration curve between humans and animals for oral and intravenous investigational drugs. J Clin Pharmacol. 46:674–692.
   PubMed Web of Science ®Google Scholar
• Gentry PR, Covington TR, Andersen ME, Clewell HJ. 2002. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol Pharmacol. 36:51–68.
   PubMed Web of Science ®Google Scholar
• Gentry PR, Covington T, Clewell H, Anderson M. 2003. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone. J Toxicol Environ Health Part A. 66:2209–2225.
   PubMed Web of Science ®Google Scholar
• Gentry PR, Haber LT, McDonald TB, Zhao Q, Covington T, Nance P, Clewell III HJ, Lipscomb JC, Barton HC. 2004. Data for physiologically based pharmacokinetic modeling in neonatal animals: physiological parameters in mice and Sprague-Dawley rats. J Children’s Health. 2:363–411.
   Google Scholar
• Haber L. 2007. Overview of approach to noncancer risk assessment. In: Lipscomb JC, Ohanian E, editor. Toxicokinetics and risk assessment. New York, NY: Informa Healthcare; p. 1–25.
   Google Scholar
• Hasegawa R, Hirata-Koizumi M, Dourson ML, Parker A, Ono A, Hirose A. 2013. Safety assessment of boron by application of new uncertainty factors and their subdivision. Regul Toxicol Pharmacol. 65:108–114.
   PubMed Web of Science ®Google Scholar
• Health Canada 2001a. Priority Substances List Assessment Report for 2-Buthoxyethanol. Environment Canada, Health Canada. Available from: http://www.hc-sc.gc.ca/ewh-semt/pubs/contaminants/psl2-lsp2/2_butoxyethanol/index-eng.php
   Google Scholar
• Health Canada. 2001b. Environment Canada, Health Canada. Priority substances list assessment report for chloroform. Available from: http://www.hc-sc.gc.ca/ewh-semt/pubs/contaminants/psl2-lsp2/chloroform/index-eng.php
   Google Scholar
• Health Canada 2006. Guidelines for Canadian drinking water quality: guideline technical document. Trihalomethanes. Federal-Provincial-Territorial Committee on Drinking Water of the Federal-Provincial-Territorial Committee on Health and the Environment, Health Canada, Ottawa, Ontario, May 2006 (with April 2009 addendum). Available from: http://www.hc-sc.gc.ca/ewh-semt/alt_formats/pdf/pubs/water-eau/trihalomethanes/trihalomethanes-eng.pdf
   Google Scholar
• Health Canada. 2013. Guideline technical document. Guidelines for Canadian drinking water quality: guideline technical document – vinyl chloride. Water and Air Quality Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Ontario. (Cat.: H144-13/6-2013E-PDF). Available from: http://www.hc-sc.gc.ca/ewh-semt/alt_formats/pdf/pubs/water-eau/vinyl_chloride/vinyl_chloride-eng.pdf
   Google Scholar
• Health Canada. 2014a. Guideline technical document. Guidelines for Canadian drinking water quality: guideline technical document — toluene, ethylbenzene and xylenes. Water and Air Quality Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Ontario. (Catalogue No H144-20/2015E-PDF). Available from: https://www.canada.ca/content/dam/canada/health-canada/migration/healthy-canadians/publications/healthy-living-vie-saine/water-toluene-eau/alt/water-toluene-eau-eng.pdf
   Google Scholar
• Health Canada. 2014b. Guideline technical document (draft for public comment). Tetrachloroethylene in drinking water. Released June 2014. Federal-Provincial-Territorial Committee on Drinking Water. Available from: http://www.hc-sc.gc.ca/ewh-semt/alt_formats/pdf/consult/_2014/tetrachloroethylene/consult-eng.pdf
   Google Scholar
• Health Canada. 2015. Draft, public consultation version. Bromate in drinking water. Released on November 27, 2015. Available from: http://www.healthycanadians.gc.ca/health-system-systeme-sante/consultations/bromate/document-eng.php
   Google Scholar
• Health Canada 2016. Sulfoxaflor Registration Decision RD2016-12, Sulfoxaflor, 1 April 2016. Available from: http://www.hc-sc.gc.ca/cps-spc/pubs/pest/_decisions/rd2016-12/index-eng.php [further details noted in 2015 draft compared to 2016 final].
   Google Scholar
• HPA (Health Protection Agency). 2007. Comparison of processes and procedures for deriving exposure criteria for the protection of human health: chemicals, ionising radiation and non-ionising radiation. Health Protection Agency, RCE-3, 2007. [cited 2016 Jan 6]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/335159/RCE-3_protectionHH_July07_full.pdf
   Google Scholar
• JECFA (Joint FAO/WHO Expert Committee on Food Additives). 2004. Evaluation of certain food additives and contaminants. Methylmercury. TRS 922. Available from: http://whqlibdoc.who.int/trs/WHO_TRS_922.pdf?ua=1
   Google Scholar
• JECFA (Joint FAO/WHO Joint Expert Committee on Food Additives). 2007. Evaluation of certain food additives and contaminants. Methylmercury. TRS 940. JECFA 67. Available from: http://apps.who.int/iris/bitstream/10665/43592/1/WHO_TRS_940_eng.pdf
   Google Scholar
• JECFA (Joint FAO/WHO Expert Committee on Food Additives). 2009. A risk-based decision tree approach for the safety evaluation of residues of veterinary drugs, WHO, Geneva. [cited 2016 Jan 6]. Available from: http://www.who.int/foodsafety/chem/jecfa/decision_tree_mar_2009_final_for_web.pdf
   Google Scholar
• JECFA (Joint FAO/WHO Expert Committee on Food Additives). 2011a. Evaluation of certain food additives and contaminants. Cadmium. WHO TRS 960. Available from: http://apps.who.int/iris/bitstream/10665/44515/1/WHO_TRS_960_eng.pdf
   Google Scholar
• JECFA (Joint FAO/WHO Joint Expert Committee on Food Additives). 2011b. Evaluation of certain contaminants in food. Deoxynivalenol. TRS 959. JECFA 72. Available from: http://whqlibdoc.who.int/trs/WHO_TRS_959_eng.pdf?ua=1
   Google Scholar
• JECFA (Joint FAO/WHO Expert Committee on Food Additives). 2013. Evaluation of certain food additives and contaminants. Cadmium. WHO TRS 983. JECFA 77. Available from: http://apps.who.int/iris/bitstream/10665/98388/1/9789241209830_eng.pdf?ua=1
   Google Scholar
• JMPR (Joint Meeting on Pesticide Residues). 2001. Pesticide residues in food – 2000: Report of the Joint FAO/WHO Meeting on Pesticide Residues, Geneva, Switzerland, 20–29 September 2000. ISBN 92-5-104547-X. Plant Production and Protections Papers 163, FAO, Rome.
   Google Scholar
• JMPR (Joint FAO/WHO Expert Meeting on Pesticide Residues). 2006. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Core Assessment Group on Pesticide Residues, Rome, Italy, 3–12 October 2006. Available from: http://www.fao.org/fileadmin/templates/agphome/documents/Pests_Pesticides/JMPR/JMPRrepor2006.pdf
   Google Scholar
• JMPR (Joint FAO/WHO Expert Meeting on Pesticide Residues). 2007. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Core Assessment Group on Pesticide Residues, Geneva, Switzerland, 18–27 September 2007. Available from: http://www.fao.org/fileadmin/templates/agphome/documents/Pests_Pesticides/JMPR/report2007jmpr.pdf
   Google Scholar
• JMPR (Joint FAO/WHO Expert Meeting on Pesticide Residues). 2008. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Core Assessment Group on Pesticide Residues, Rome, Italy, 9–18 September 2008. Available from: http://www.fao.org/fileadmin/templates/agphome/documents/Pests_Pesticides/JMPR/JMPRReport08.pdf
   Google Scholar
• Kirman CR, Sweeney LM, Corley R, Gargas ML. 2005. Using physiologically‐based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate. Risk Anal. 25:271–284.
   PubMed Web of Science ®Google Scholar
• Kirman CR, Sweeney LM, Gargas ML, Strother DE, Collins JJ, Deskin R. 2008. Derivation of noncancer reference values for acrylonitrile. Risk Anal. 28:1375–1394.
   PubMed Web of Science ®Google Scholar
• Kirman CR, Grant RL. 2012. Quantitative human health risk assessment for 1, 3-butadiene based upon ovarian effects in rodents. Regul Toxicol Pharmacol. 62:371–384.
   PubMed Web of Science ®Google Scholar
• KemI (The Swedish National Chemicals Inspectorate). 2003. Proposals for the use of assessment (uncertainty) factors: Application to risk assessment for plant protection products, industrial chemicals and biocidal products within the European Union. Stockholm, Sweden.
   Google Scholar
• Lehman AJ, Fitzhugh OG. 1954. Ten-fold safety factor studies. Assoc. Food Drug Off US Q Bull XVIII. 1:33–35.
   Google Scholar
• Liao KH, Tan YM, Conolly RB, Borghoff SJ, Gargas ML, Andersen ME, Clewell HJ. 2007. Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode‐of‐action‐based cancer risk assessment for chloroform. Risk Anal. 27:1535–1551.
   PubMed Web of Science ®Google Scholar
• Loizou G, Spendiff M, Barton HA, Bessems J, Bois FY, d’Yvoire MB, Buist H, Clewell HJ, Meek B, Gundert-Remy U, Goerlitz G. 2008. Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps. Regul Toxicol Pharmacol. 50:400–411.
   PubMed Web of Science ®Google Scholar
• Lu Y, Rieth S, Lohitnavy M, Dennison J, El-Masri H, Barton HA, Bruckner J, Yang RS. 2008. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane. Regul Toxicol Pharmacol. 50:249–260.
   PubMed Web of Science ®Google Scholar
• Meek ME, Ohanian E, Renwick A, Naumann B, Lake B, Vu V, Dourson M. 1999. Guidelines for application of data-derived uncertainty factors in risk assessment. Report of a Meeting by Toxicology Excellence for Risk Assessment for US EPA/Health Canada, Washington, March 25th–26th.
   Google Scholar
• Meek ME, Renwick A, Ohanian E, Dourson M, Lake B, Naumann BD, Vu V. 2002. Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment. Toxicology. 181-182:115–120.
   PubMed Web of Science ®Google Scholar
• Meek ME, Boobis AR, Crofton KM, Heinemeyer G, Van Raaij M, Vickers C. 2011. Risk assessment of combined exposure to multiple chemicals: a WHO/IPCS framework. Regul Toxicol Pharmacol. 60:S1–S14.
   PubMed Web of Science ®Google Scholar
• Meek ME, Barton HG, Bessems J, G, Lipcomb J, C, Krishnan K. 2013. Case study illustrating the WHO/IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment. Regul. Toxicol. Pharmacol. 66:116–129.
   PubMed Web of Science ®Google Scholar
• Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, Seed J, Vickers C. 2014a. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J Appl Toxicol. 34:1–18.
   PubMed Web of Science ®Google Scholar
• Meek ME, Palermo CM, Bachman AN, North CM, Jeffrey Lewis R. 2014b. Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol. 34:595–606.
   PubMed Web of Science ®Google Scholar
• MDH (Minnesota Department of Health). 2015. Bisphenol A. CAS: 80-05-7. Health Risk Limits for Groundwater. Health Risk Assessment Unit, Environmental Health Division. Available from: http://www.health.state.mn.us/divs/eh/risk/guidance/gw/bpatoxsumm.pdf
   Google Scholar
• Mörk AK, Jonsson F, Johanson G. 2014. Adjustment factors for toluene, styrene and methyl chloride by population modeling of toxicokinetic variability. Reg Toxicol Pharmacol. 69:78–90.
   PubMed Web of Science ®Google Scholar
• Mörk AK, Johanson G. 2010. Chemical specific adjustment factors for intra-species variability of acetone toxicokinetics using a probabilistic approach. Toxicol Sci. 116:336–348.
   PubMed Web of Science ®Google Scholar
• National Research Council (NRC). (2007). Toxicity testing in the 21st century: a vision and a strategy. Washington, DC: National Academy Press.
   Google Scholar
• Naumann BD, Silverman KC, Dixit R, Faria EC, Sargent EV. 2001. Case studies for catergorical data-derived adjustment factors. Human Ecol. Risk Assess. 7:61–105.
   Web of Science ®Google Scholar
• NIHS Japan. Personal communication from Akihiko Hirose to WHO in response to Call-for-Data. 3 September, 2015. CSAF approach for boron assessment.
   Google Scholar
• OECD (Organisation of Economic Co-operation and Development). 2012. Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology – Important Issues on Risk Assessment of Manufactured Nanomaterials ENV/JM/MONO(2012)8. [cited 2016 Jan 6]. Available from: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2012)8&doclanguage=en
   Google Scholar
• OECD (Organization for Economic Cooperation and Development). 2016. Users' Handbook supplement to the Guidance Document for developing and accessing Adverse Outcome Pathways. OECD Series on Adverse Outcome Pathways. Available from: http://dx.doi.org/10.1787/2415170X. July
   Google Scholar
• Pelekis M, Gephart LA, Lerman SE. 2001. Physiological-model-based derivation of the adult and child pharmacokinetic Human Variability uncertainty factors for volatile organic compounds. Regul Toxicol Pharmacol. 33:12–20.
   PubMed Web of Science ®Google Scholar
• Poet TS, Kirman CR, Bader M, van Thriel C, Gargas ML, Hinderliter PM. 2010. Quantitative risk analysis for N-methyl pyrrolidone using physiologically based pharmacokinetic and benchmark dose modeling. Toxicol Sci. 113:468–482.
   PubMed Web of Science ®Google Scholar
• Poet TS, Schlosser PM, Rodriguez CE, Parod RJ, Rodwell DE, Kirman CR. 2016. Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone. Regul. Toxicol. Pharmacol. 76:102–122.
   PubMed Web of Science ®Google Scholar
• Price PS, Keenan RS, Schwab B. 1999. Defining the interindividual (intraspecies) uncertainty factor. Human Ecol. Risk Assess. 5:1023–1033.
   Web of Science ®Google Scholar
• Renwick AG. 1991. Safety factors and establishment of acceptable daily intakes. Food Addit Contam. 8:135–149.
   PubMed Web of Science ®Google Scholar
• Renwick AG. 1993. Data-derived safety factors for the evaluation of food additives and environmental contaminants. Food Addit Contam. 10:275–305.
   PubMed Web of Science ®Google Scholar
• Renwick AG, Lazarus NR. 1998. Human variability and noncancer risk assessment–an analysis of the default uncertainty factor. Regul. Toxicol. Pharmacol. 27:3–20.
   PubMed Web of Science ®Google Scholar
• Sarangapani R, Gentry PR, Covington TR, Teeguarden JG, Clewell HJ, III. 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal. Toxicol. 15:987–1016.
   PubMed Web of Science ®Google Scholar
• Silverman KC, Naumann BD, Holder DJ, Dixit R, Faria EC, Sargent EV, Gallo MA. 1999. Establishing data-derived adjustment factors from published pharmaceutical clinical trial data. Human Ecol. Risk Assess. 5:1059–1089.
   Web of Science ®Google Scholar
• Sweeney LM, Kirman CR, Gargas ML, Carson ML, Tardiff RG. 2010. Development of a physiologically-based toxicokinetic model of acrylamide and glycidamide in rats and humans. Food Chem Toxicol. 48:668–685.
   PubMed Web of Science ®Google Scholar
• TCEQ (Texas Commission on Environmental Quality). 2015. 1,3-butadiene. CAS Registry Number: 106-99-0. Development Support Document. Available from: https://www.tceq.texas.gov/assets/public/implementation/tox/dsd/final/butadiene,%201,3-.pdf
   Google Scholar
• Troutman JA, Rick DL, Stuard SB, Fisher J, Bartels MJ. 2015. Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment. Regul Toxicol Pharmacol. 73:530–543.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Kirman CR, Proctor DM, Haws LC, Suh M, Hays SM, Hixon JG, Harris MA. 2014. A chronic oral reference dose for hexavalent chromium‐induced intestinal cancer. J Appl Toxicol. 34:525–536.
   PubMed Web of Science ®Google Scholar
• UK COT (UK Committee on Toxicity). 2006. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. COT Statement on the Tolerable Daily Intake for Perfluorooctanoic Acid. Available from: http://cot.food.gov.uk/sites/default/files/cot/cotstatementpfoa200610.pdf
   Google Scholar
• UK COT (United Kingdom Committee on Toxicity). 2007. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. Variability and Uncertainty in Toxicology of Chemicals in Food, Consumer Products and the Environment. [cited 2016 Jan 6]. Available from: http://cot.food.gov.uk/sites/default/files/cot/vutreportmarch2007.pdf
   Google Scholar
• UK COT (UK Committee on Toxicity). 2009. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. Update statement on the Tolerable Daily Intake for Perfluorooctanoic Acid. Available from: http://cot.food.gov.uk/sites/default/files/cot/cotstatementpfoa200902.pdf
   Google Scholar
• UK EA (United Kingdom Environmental Agency). 2009. Human health toxicological assessment of contaminants in soil. Science Report – Final SC050021/SR2. [cited 2016 Jan 6]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/291011/scho0508bnqy-e-e.pdf
   Google Scholar
• US EPA (US Environmental Protection Agency). 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. Office of Research and Development. EPA/600/8-90/066F. Research Triangle Park, NC.
   Google Scholar
• US EPA (US Environmental Protection Agency). 2000. Toxicological review of vinyl chloride. CAS No. 75-01-4. In Support of Summary Information on the Integrated Risk Information System (IRIS), U.S. Environmental Protection Agency, Washington, DC Available from: http://cfpub.epa.gov/ncea/iris/iris_documents/documents/toxreviews/1001tr.pdf
   Google Scholar
• US EPA (US Environmental Protection Agency). 2001. Water quality criterion for the protection of human health: methylmercury. EPA/823/R 01/001. Washington, DC: U.S. Environmental Protection Agency, Office of Water. Available from: http://www.waterboards.ca.gov/water_issues/programs/tmdl/records/state_board/2008/ref2664.pdf
   Google Scholar
• US EPA (US Environmental Protection Agency). 2002. A review of the reference dose and reference concentration process. U.S. Environmental Protection Agency. Risk Assessment Forum. EPA/630/P-02/00F. Washington DC 20460.
   Google Scholar
• US EPA (Environmental Protection Agency). 2004. IRIS toxicological review of boron and compounds. Available from: http://cfpub.epa.gov/ncea/iris/iris_documents/documents/toxreviews/0410tr.pdf
   Google Scholar
• US EPA (Environmental Protection Agency). 2006. Revised Reregistration Eligibility Decision for MSMA, DSMA, CAMA, and Cacodylic Acid. Office of Pesticide Programs and Toxic Substances (OPPTS), Washington, DC. Available from: https://archive.epa.gov/pesticides/reregistration/web/pdf/organic_arsenicals_red.pdf
   Google Scholar
• US EPA (US Environmental Protection Agency). 2007. N-methyl carbamates revised cumulative risk assessment. Office of Pesticide Programs. Washington DC. Available from: http://www.regulations.gov/#!docketDetail;D=EPA-HQ-OPP-2007-0935
   Google Scholar
• US EPA (US Environmental Protection Agency). 2009. Provisional Health Advisories for Perfluorooctanoic Acid (PFOA) and Perfluorooctyl Sulfonate (PFOS). Available from: https://www.epa.gov/sites/production/files/2015-09/documents/pfoa-pfos-provisional.pdf
   Google Scholar
• US EPA (US Environmental Protection Agency). 2010. Toxicological review of ethylene glycol monobutyl ether (EGBE). (CAS No. 111-76-2. In Support of Summary Information on the Integrated Risk Information System (IRIS), U.S. Environmental Protection Agency, Washington, DC. Available from: https://cfpub.epa.gov/ncea/iris/iris_documents/documents/toxreviews/0500tr.pdf
   Google Scholar
• US EPA (US Environmental Protection Agency). 2011. Recommended Use of Body Weight ¾ as the Default Method in Derivation of the Oral Reference Dose. U.S. Environmental Protection Agency, Risk Assessment Forum. EPA/100/R11/0001.
   Google Scholar
• US EPA (U.S. Environmental Protection Agency). 2012a. Advances in Inhalation Gas Dosimetry for Derivation of a Reference Concentration (RfC) and Use in Risk Assessment. National Center for Environmental Assessment. EPA/600/R-12/044. Washington, DC 20460.
   Google Scholar
• US EPA (Environmental Protection Agency). 2012b (draft). TSCA Work Plan Chemical Risk Assessment. N-methylpyrrolidone: paint stripper use. CAS#872-50-4. External Review Draft, December 2012. Office of Chemical Safety and Pollution Prevention, Washington, DC. Available from: http://www.scgcorp.com/dcm-nmp2013/PDFs/NMP%20Draft%20Risk%20Assessment%20(External%20Review%20Draft).pdf
   Google Scholar
• US EPA (U.S. Environmental Protection Agency). 2014. Guidance for applying quantitative data to develop data-derived extrapolation factors for interspecies and intraspecies extrapolation. Risk Assessment Forum. EPA/100/R-14/002F. Washington (DC) 20460.
   Google Scholar
• US EPA (US Environmental Protection Agency). 2015. TSCA Work Plan Chemical Risk Assessment. N-methylpyrrolidone: paint stripper use. CAS#872-50-4. EPA/740/R1/5002, March 2015. Available from: http://www.epa.gov/sites/production/files/2015-11/documents/nmp_ra_3_23_15_final.pdf
   Google Scholar
• US EPA (Environmental Protection Agency). 2016a. PFOA. Health effects support document for perfluorooctanoic acid (PFOA). Health and ecological criteria division, Washington, DC. EPA Document Number: 822-R-16-003. May 2016. Available from: https://www.epa.gov/sites/production/files/2016-05/documents/pfoa_hesd_final-plain.pdf
   Google Scholar
• US EPA (Environmental Protection Agency). 2016b. Health effects support document for perfluorooctane sulfonate (PFOS). Health and ecological criteria division, Washington, DC. EPA Document Number: 822-R-16-002. May 2016. Available from: https://www.epa.gov/sites/production/files/2016-05/documents/hesd_pfos_final-plain.pdf
   Google Scholar
• Valcke M, Krishnan K. 2014. Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants. J Appl Toxicol. 34:227–240.
   PubMed Web of Science ®Google Scholar
• Valcke M, Krishnan K. 2011. Assessing the impact of the duration and intensity of inhalation exposure on the magnitude of the variability of internal dose metrics in children and adults. Inhal Toxicol. 23:863–877.
   PubMed Web of Science ®Google Scholar
• WHO/IPCS (World Health Organization/International Programme on Chemical Safety). 1994. Environmental Health Criteria 170: Assessing human health risks of chemicals: Derivation of guidance values for health-based exposure limits. WHO/IPCS. Geneva, Switzerland. Available from: http://www.inchem.org/documents/ehc/ehc/ehc170.htm
   Google Scholar
• WHO/IPCS (World Health Organization/International Programme on Chemical Safety). 2005. Chemical-Specific Adjustment Factors (CSAF) for interspecies differences and human variability: guidance document for the use of data in dose/concentration-response assessment. (IPCS harmonization project document no. 2). WHO/IPCS/01.4, 1-96. Geneva, Switzerland. Available from: http://www.inchem.org/documents/harmproj/harmproj/harmproj2.pdf
   Google Scholar
• WHO/IPCS (World Health Organization/International Programme on Chemical Safety). 2010. Characterization and application of physiologically based pharmacokinetic models in risk assessment. (IPCS harmonization project document no. 9). Geneva, Switzerland. Available from: http://www.who.int/ipcs/methods/harmonization/areas/pbpk/en/
   Google Scholar
• WHO/IPCS (World Health Organization/International Programme on Chemical Safety). 2014. Guidance document on evaluating and expressing uncertainty in hazard characterization. (IPCS harmonization project document no. 11). Geneva, Switzerland. Available from: http://www.who.int/ipcs/methods/harmonization/uncertainty_in_hazard_characterization.pdf
   Google Scholar
• Yang X, Morris SM, Gearhart JM, Ruark CD, Paule MG, Slikker Jr W, Mattison DR, Vitiello B, Twaddle NC, Doerge DR, et al. 2014. Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates. PloS One. 9:e106101.
   PubMed Web of Science ®Google Scholar
• Yoon M, Campbell JL, Andersen ME, Clewell HJ. 2012. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. Crit Rev Toxicol. 42:633–652.
   PubMed Web of Science ®Google Scholar